Delaware C-Corp · Pre-Seed

Cross-border
healthcare
intelligence.

Krivox Inc. operates Apex Opinion, a platform connecting patients across emerging markets to US board-certified physicians for expert second opinions. Better access. Better outcomes. A better model.

scroll

Why This Matters

A $6B+ market. No clear winner.

Millions of patients in emerging markets face life-altering diagnoses with no structured way to access a second opinion from a US specialist. The ones who try navigate unstructured channels: hospital websites, email referrals, medical tourism brokers. Apex Opinion replaces that friction with a platform.

The Problem

Diagnosis Without a Second Voice

30% of complex diagnoses are changed or refined upon independent specialist review. For patients in emerging markets, accessing that review means traveling internationally, navigating foreign hospital systems, or simply going without. The gap between need and access is enormous.

Patient Access Crisis

The Platform

Structured, Scalable, Capital-Efficient

Apex Opinion is a marketplace designed to become rapidly self-sustaining. The architecture is designed to generate durable advantages as the network scales. The full thesis is available to qualified investors under NDA.

Request Memorandum

Apex Opinion

A platform connecting patients to the physicians who can help.

Patients upload their medical records securely. A US board-certified specialist on the Apex Opinion network reviews the case and delivers a comprehensive second opinion report, typically within 5 to 7 business days.

US board-certified physicians across oncology, cardiology, orthopedics, and more

HIPAA-compliant platform with end-to-end encryption

Written reports, video consultations, and multi-disciplinary team reviews

Global Reach

Multiple markets. One platform.

Apex Opinion is designed to serve patients across emerging markets in Asia, the Middle East, and Latin America, where demand for US specialist access far exceeds structured supply. Each market is selected and sequenced based on patient demand intensity, regulatory readiness, and strategic value. The detailed geographic roadmap is available to qualified investors under NDA.

The Opportunity

$1.3B+ Serviceable Market

The global medical second opinion market exceeds $6B and is projected to reach $12B to $29B by 2035, growing at 6 to 18% CAGR depending on source. Cross-border telehealth demand is accelerating fastest in markets where specialist density is lowest and digital health adoption is highest.

Underserved + Growing

The Approach

Phased, Capital-Efficient Expansion

Markets are entered sequentially, with each geography proving unit economics before the next is activated. This phased approach preserves capital, validates demand, and compounds operational advantages over time.

Roadmap Under NDA

Leadership

Saurabh Sanon, MD

Founder & CEO, Krivox Inc.

Interventional cardiologist and entrepreneur who sees the diagnostic gaps firsthand. Patients in emerging markets face life-changing decisions with limited access to specialist review. Krivox was built to close that gap: giving patients direct access to US board-certified physicians through a platform designed for scale, compliance, and operational rigor.

Interventional Cardiologist Founder & CEO Delaware C-Corp

Get Involved

Two ways to join the mission.

For Investors

Krivox is raising a $1M pre-seed round via Post-Money SAFE notes. The full thesis, including our proprietary competitive moat, is available under NDA. If you invest in healthtech or emerging market infrastructure, we should talk.

For Physicians

Apex Opinion is building a curated panel of exceptional US board-certified specialists. We are selective by design: every physician on the panel reflects the clinical standard our users depend on. If you are accepted, you review cases remotely, on your own schedule, from anywhere. No overhead. No insurance paperwork. No payer negotiations. Just clinical work that pays well, deposited directly.

Cross-border healthcare intelligence.